RELATED SERVICES
Amy Lange Miller focuses her practice on intellectual property disputes with an emphasis on patent litigation in the life sciences and pharmaceutical industries, including litigation involving the Hatch-Waxman provisions of the Patent Act. She also has advised clients on drug launch risks, litigation strategy, freedom to operate and patent allowance.
Amy Lange Miller focuses her practice on intellectual property disputes with an emphasis on patent litigation in the life sciences and pharmaceutical industries, including litigation involving the Hatch-Waxman provisions of the Patent Act. She also has advised clients on drug launch risks, litigation strategy, freedom to operate and patent allowance.
Previously, Amy was a registered nurse coordinating clinical trials of investigational drugs for U.S. Food and Drug Administration approval in the areas of pain management biologics and viral gene therapy. She also worked in research and co-authored several scientific articles on gene therapy and clotting factors. Amy relies on her experience in the drug research and development lifecycle in litigation and in counseling clients in the life sciences and pharmaceutical industries.